From the Blood to the Central Nervous System: A Nanoparticle's Journey Through the Blood–Brain Barrier by Transcytosis

International Review of Neurobiology

Volumn 130, Issue , 2016, Pages 41-72

  Fullstone, G ^a   Nyberg, S ^a,b   Tian, X ^c   Battaglia, G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Institute of Clinical Evaluative Sciences   (Canada)

^c ANHUI UNIVERSITY   (China)

Author keywords

Blood brain barrier; Central nervous system; Drug delivery; Intracellular trafficking; Nanoparticles; Receptor binding; Receptor recycling; Transcytosis

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; APOLIPOPROTEIN E; APOLIPOPROTEIN E RECEPTOR 2; FC RECEPTOR; GOLD NANOPARTICLE; INSULIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MACROGOL; MEGALIN; MELANOTRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; NANOPARTICLE;

BLOOD BRAIN BARRIER; BRAIN ENDOTHELIUM CELL; CELL MIGRATION; ENDOCYTOSIS; ENDOTHELIUM CELL; EXOCYTOSIS; HUMAN; IC50; IN VITRO STUDY; IN VIVO STUDY; MONTE CARLO METHOD; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR BINDING; RECEPTOR RECYCLING; TRANSCYTOSIS; ANIMAL; CENTRAL NERVOUS SYSTEM; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; HUMANS; NANOPARTICLES; TRANSCYTOSIS;

EID: 84994076422     PISSN: 00747742     EISSN: 21625514     Source Type: Book Series    
DOI: 10.1016/bs.irn.2016.06.001     Document Type: Chapter

References (97)

1. Alexis, F., Pridgen, E., Molnar, L.K., Farokhzad, O.C., Factors affecting the clearance and biodistribution of polymeric nanoparticles. Molecular Pharmaceutics 5:4 (2008), 505–515, 10.1021/mp800051m.
2. Alyautdin, R., Petrov, V., Langer, K., Berthold, A., Kharkevich, D., Kreuter, J., Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharmaceutical Research 14:3 (1997), 325–328, 10.1023/a:1012098005098.
3. Azizi, P.M., Zyla, R.E., Guan, S., Wang, C., Liu, J., Bolz, S.-S.,.. Lee, W.L., Clathrin-dependent entry and vesicle-mediated exocytosis define insulin transcytosis across microvascular endothelial cells. Molecular Biology of the Cell 26:4 (2015), 740–750, 10.1091/mbc.E14-08-1307.
4. Banks, W.A., The source of cerebral insulin. European Journal of Pharmacology 490:1–3 (2004), 5–12 http://dx.doi.org/10.1016/j.ejphar.2004.02.040.
5. Bien-Ly, N., Yu, Y.J., Bumbaca, D., Elstrott, J., Boswell, C.A., Zhang, Y.,.. Watts, R.J., Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants. The Journal of Experimental Medicine 211:2 (2014), 233–244, 10.1084/jem.20131660.
6. Boado, R.J., Zhou, Q.-H., Lu, J.Z., Hui, E.K.-W., Pardridge, W.M., Pharmacokinetics and brain uptake of a genetically engineered bi-functional fusion antibody targeting the mouse transferrin receptor. Molecular Pharmaceutics 7:1 (2010), 237–244, 10.1021/mp900235k.
7. Brightman, M.W., Reese, T.S., Junctions between intimately apposed cell membranes in the vertebrate brain. The Journal of Cell Biology 40:3 (1969), 648–677, 10.1083/jcb.40.3.648.
8. Broadwell, R.D., Balin, B.J., Salcman, M., Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proceedings of the National Academy of Sciences of the United States of America 85:2 (1988), 632–636.
9. Brodsky, F.M., Chen, C.-Y., Knuehl, C., Towler, M.C., Wakeham, D.E., Biological basket weaving: Formation and function of clathrin-coated vesicles. Annual Review of Cell and Developmental Biology 17:1 (2001), 517–568, 10.1146/annurev.cellbio.17.1.517.
10. Bu, G., Maksymovitch, E.A., Geuze, H., Schwartz, A.L., Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells. Journal of Biological Chemistry 269:47 (1994), 29874–29882.
11. Bundgaard, M., Frøkjaer-Jensen, J., Crone, C., Endothelial plasmalemmal vesicles as elements in a system of branching invaginations from the cell surface. Proceedings of the National Academy of Sciences of the United States of America 76:12 (1979), 6439–6442.
12. Cabezón, I., Manich, G., Martín-Venegas, R., Camins, A., Pelegrí, C., Vilaplana, J., Trafficking of gold nanoparticles coated with the 8D3 anti-transferrin receptor antibody at the mouse blood–brain barrier. Molecular Pharmaceutics 12:11 (2015), 4137–4145, 10.1021/acs.molpharmaceut.5b00597.
13. Canton, I., Battaglia, G., Endocytosis at the nanoscale. Chemical Society Reviews 41:7 (2012), 2718–2739, 10.1039/c2cs15309b.
14. Coomber, B.L., Stewart, P.A., Morphometric analysis of CNS microvascular endothelium. Microvascular Research 30:1 (1985), 99–115 http://dx.doi.org/10.1016/0026-2862(85)90042-1.
15. Deane, R., Wu, Z., Zlokovic, B.V., RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood–brain barrier. Stroke 35:11 Suppl. 1 (2004), 2628–2631, 10.1161/01.STR.0000143452.85382.d1.
16. Decuzzi, P., Ferrari, M., The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 27:30 (2006), 5307–5314, 10.1016/j.biomaterials.2006.05.024.
17. Decuzzi, P., Ferrari, M., The receptor-mediated endocytosis of nonspherical particles. Biophysical Journal 94:10 (2008), 3790–3797 http://dx.doi.org/10.1529/biophysj.107.120238.
18. Demeule, M., Currie, J.-C., Bertrand, Y., Ché, C., Nguyen, T., Régina, A.,.. Béliveau, R., Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. Journal of Neurochemistry 106:4 (2008), 1534–1544, 10.1111/j.1471-4159.2008.05492.x.
19. Demeule, M., Poirier, J., Jodoin, J., Bertrand, Y., Desrosiers, R.R., Dagenais, C.,.. Béliveau, R., High transcytosis of melanotransferrin (P97) across the blood–brain barrier. Journal of Neurochemistry 83:4 (2002), 924–933, 10.1046/j.1471-4159.2002.01201.x.
20. Demeule, M., Régina, A., Ché, C., Poirier, J., Nguyen, T., Gabathuler, R.,.. Béliveau, R., Identification and design of peptides as a new drug delivery system for the brain. Journal of Pharmacology and Experimental Therapeutics 324:3 (2008), 1064–1072, 10.1124/jpet.107.131318.
21. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B.,.. Kurzchalia, T.V., Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:5539 (2001), 2449–2452, 10.1126/science.1062688.
22. Dulubova, I., Khvotchev, M., Liu, S., Huryeva, I., Südhof, T.C., Rizo, J., Munc18-1 binds directly to the neuronal SNARE complex. Proceedings of the National Academy of Sciences of the United States of America 104:8 (2007), 2697–2702, 10.1073/pnas.0611318104.
23. Ehrlich, M., Boll, W., van Oijen, A., Hariharan, R., Chandran, K., Nibert, M.L., Kirchhausen, T., Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 118:5 (2004), 591–605, 10.1016/j.cell.2004.08.017.
24. Fornaguera, C., Caldero, G., Mitjans, M., Vinardell, M.P., Solans, C., Vauthier, C., Interactions of PLGA nanoparticles with blood components: Protein adsorption, coagulation, activation of the complement system and hemolysis studies. Nanoscale 7:14 (2015), 6045–6058, 10.1039/c5nr00733j.
25. Fornaguera, C., Dols-Perez, A., Calderó, G., García-Celma, M.J., Camarasa, J., Solans, C., PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier. Journal of Controlled Release 211 (2015), 134–143 http://dx.doi.org/10.1016/j.jconrel.2015.06.002.
26. Frank, P.G., Woodman, S.E., Park, D.S., Lisanti, M.P., Caveolin, caveolae, and endothelial cell function. Arteriosclerosis, Thrombosis, and Vascular Biology 23:7 (2003), 1161–1168, 10.1161/01.atv.0000070546.16946.3a.
27. Friden, P.M., Walus, L.R., Musso, G.F., Taylor, M.A., Malfroy, B., Starzyk, R.M., Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proceedings of the National Academy of Sciences of the United States of America 88:11 (1991), 4771–4775.
28. Fu, J., Naren, A.P., Gao, X., Ahmmed, G.U., Malik, A.B., Protease-activated receptor-1 activation of endothelial cells induces protein kinase Cα-dependent phosphorylation of syntaxin 4 and Munc18c: Role in signaling P-selectin expression. Journal of Biological Chemistry 280:5 (2005), 3178–3184, 10.1074/jbc.M410044200.
29. Fullstone, G., Wood, J., Holcombe, M., Battaglia, G., Modelling the transport of nanoparticles under blood flow using an agent-based approach. Scientific Reports, 5, 2015, 10649, 10.1038/srep10649 http://www.nature.com/srep/2015/150610/srep10649/abs/srep10649.html supplementary-information.
30. Fung, L.K., Shin, M., Tyler, B., Brem, H., Saltzman, W.M., Chemotherapeutic drugs released from polymers: Distribution of 1,3-bis(2-chloroethyl)-l-nitrosourea in the rat brain. Pharmaceutical Research 13 (1996), 671–682.
31. Gadkar, K., Yadav, D.B., Zuchero, J.Y., Couch, J.A., Kanodia, J., Kenrick, M.K.,.. Ramanujan, S., Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain. European Journal of Pharmaceutics and Biopharmaceutics 101 (2016), 53–61 http://dx.doi.org/10.1016/j.ejpb.2016.01.009.
32. Gaillard, P.J., Visser, C.C., de Boer, A.G., Targeted delivery across the blood-brain barrier. Expert Opinion on Drug Delivery 2:2 (2005), 299–309, 10.1517/17425247.2.2.299.
33. Gao, K., Jiang, X., Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. International Journal of Pharmaceutics 310:1–2 (2006), 213–219 http://dx.doi.org/10.1016/j.ijpharm.2005.11.040.
34. Gao, H., Zhang, S., Cao, S., Yang, Z., Pang, Z., Jiang, X., Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery. Molecular Pharmaceutics 11:8 (2014), 2755–2763, 10.1021/mp500113p.
35. Geng, Y.A.N., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., Discher, D.E., Shape effects of filaments versus spherical particles in flow and drug delivery. Nature Nanotechnology 2:4 (2007), 249–255, 10.1038/nnano.2007.70.
36. Gosk, S., Vermehren, C., Storm, G., Moos, T., Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion. Journal of Cerebral Blood Flow and Metabolism 24:11 (2004), 1193–1204.
37. Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S.,.. Müller, R.H., ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids and Surfaces. B, Biointerfaces 18:3–4 (2000), 301–313 http://dx.doi.org/10.1016/S0927-7765(99)00156-3.
38. Guerin, C., Olivi, A., Weingart, J.D., Lawson, H.C., Brem, H., Recent advances in brain tumor therapy: Local intracerebral drug delivery by polymers. Investigational New Drugs 22 (2004), 27–37.
39. Henley, J.R., Krueger, E.W.A., Oswald, B.J., McNiven, M.A., Dynamin-mediated Internalization of Caveolae. The Journal of Cell Biology 141:1 (1998), 85–99, 10.1083/jcb.141.1.85.
40. Herz, J., Marschang, P., Coaxing the LDL receptor family into the fold. Cell 112:3 (2003), 289–292 http://dx.doi.org/10.1016/S0092-8674(03)00073-4.
41. Herz, J., Strickland, D.K., LRP: A multifunctional scavenger and signaling receptor. Journal of Clinical Investigation 108:6 (2001), 779–784.
42. Hong, W., SNAREs and traffic. Biochimica et Biophysica Acta 1744:2 (2005), 120–144 http://dx.doi.org/10.1016/j.bbamcr.2005.03.014.
43. Huwyler, J., Wu, D., Pardridge, W.M., Brain drug delivery of small molecules using immunoliposomes. Proceedings of the National Academy of Sciences of the United States of America 93:24 (1996), 14164–14169.
44. Kaetzel, C.S., Robinson, J.K., Chintalacharuvu, K.R., Vaerman, J.P., Lamm, M.E., The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: A local defense function for IgA. Proceedings of the National Academy of Sciences of the United States of America 88:19 (1991), 8796–8800.
45. Keep, R., Jones, H., A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat. Developmental Brain Research 56:1 (1990), 47–53.
46. Kissel, K., Hamm, S., Schulz, M., Vecchi, A., Garlanda, C., Engelhardt, B., Immunohistochemical localization of the murine transferrin receptor (TfR) on blood–tissue barriers using a novel anti-TfR monoclonal antibody. Histochemistry and Cell Biology 110 (1998), 63–72.
47. Kordower, J.H., Palfi, S., Chen, E.-Y., Ma, S.Y., Sendera, T., Cochran, E.J.,.. Comella, C.D., Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Annals of Neurology 46:3 (1999), 419–424, 10.1002/1531-8249(199909)46:3<419::aid-ana21>3.0.co;2-q.
48. Kreuter, J., Alyautdin, R.N., Kharkevich, D.A., Ivanov, A.A., Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Research 674:1 (1995), 171–174 http://dx.doi.org/10.1016/0006-8993(95)00023-J.
49. Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., Alyautdin, R., Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. Journal of Drug Targeting 10:4 (2002), 317–325, 10.1080/10611860290031877.
50. Martinez-Veracoechea, F.J., Frenkel, D., Designing super selectivity in multivalent nano-particle binding. Proceedings of the National Academy of Sciences of the United States of America 108:27 (2011), 10963–10968, 10.1073/pnas.1105351108.
51. Mellman, I., Endocytosis and molecular sorting. Annual Review of Cell and Developmental Biology 12:1 (1996), 575–625, 10.1146/annurev.cellbio.12.1.575.
52. Menei, P., Pean, J.M., Nerrière-Daguin, V., Jollivet, C., Brachet, P., Benoit, J.P., Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage. Experimental Neurology 161:1 (2000), 259–272 http://dx.doi.org/10.1006/exnr.1999.7253.
53. Moos, T., Morgan, E.H., Transferrin and transferrin receptor function in brain barrier systems. Cellular and Molecular Neurobiology 20 (2000), 77–95.
54. Moos, T., Morgan, E.H., Restricted transport of anti-transferrin receptor antibody (OX26) through the blood–brain barrier in the rat. Journal of Neurochemistry 79:1 (2001), 119–129, 10.1046/j.1471-4159.2001.00541.x.
55. Niewoehner, J., Bohrmann, B., Collin, L., Urich, E., Sade, H., Maier, P.,.. Freskgård, P.-O., Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron 81:1 (2014), 49–60 http://dx.doi.org/10.1016/j.neuron.2013.10.061.
56. Oh, P., Borgstrom, P., Witkiewicz, H., Li, Y., Borgstrom, B.J., Chrastina, A.,.. Schnitzer, J.E., Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nature Biotechnology 25:3 (2007), 327–337 http://www.nature.com/nbt/journal/v25/n3/suppinfo/nbt1292_S1.html.
57. Oh, P., McIntosh, D.P., Schnitzer, J.E., Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. The Journal of Cell Biology 141:1 (1998), 101–114, 10.1083/jcb.141.1.101.
58. Olivier, J.-C., Huertas, R., Lee, H.J., Calon, F., Pardridge, W.M., Synthesis of pegylated immunonanoparticles. Pharmaceutical Research 19:8 (2002), 1137–1143, 10.1023/a:1019842024814.
59. Owens, D.E., Peppas, N.A., Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. International Journal of Pharmaceutics 307:1 (2006), 93–102, 10.1016/j.ijpharm.2005.10.010.
60. Pang, Z., Lu, W., Gao, H., Hu, K., Chen, J., Zhang, C.,.. Zhu, C., Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. Journal of Controlled Release 128:2 (2008), 120–127 http://dx.doi.org/10.1016/j.jconrel.2008.03.007.
61. Pardridge, W.M., The blood-brain barrier: Bottleneck in brain drug development. NeuroRx: The Journal of the American Society for Experimental NeuroTherapeutics 2:1 (2005), 3–14, 10.1602/neurorx.2.1.3.
62. Pardridge, W.M., Buciak, J.L., Friden, P.M., Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. Journal of Pharmacology and Experimental Therapeutics 259:1 (1991), 66–70.
63. Pardridge, W.M., Kang, Y.-S., Buciak, J.L., Yang, J., Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood–brain barrier in vivo in the primate. Pharmaceutical Research 12 (1995), 807–816.
64. Pegoraro, C., Cecchin, D., Gracia, L.S., Warren, N., Madsen, J., Armes, S.P.,.. Battaglia, G., Enhanced drug delivery to melanoma cells using PMPC-PDPA polymersomes. Cancer Letters 334:2 (2013), 328–337, 10.1016/j.canlet.2013.02.007.
65. Pelkmans, L., Kartenbeck, J., Helenius, A., Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nature Cell Biology 3:5 (2001), 473–483 http://www.nature.com/ncb/journal/v3/n5/suppinfo/ncb0501_473_S1.html.
66. Pfeffer, S.R., Rab GTPases: Specifying and deciphering organelle identity and function. Trends in Cell Biology 11:12 (2001), 487–491, 10.1016/s0962-8924(01)02147-x.
67. Pozrikidis, C., The motion of particles in the Hele-Shaw cell. Journal of Fluid Mechanics 261 (1994), 199–222.
68. Predescu, D., Horvat, R., Predescu, S., Palade, G.E., Transcytosis in the continuous endothelium of the myocardial microvasculature is inhibited by N-ethylmaleimide. Proceedings of the National Academy of Sciences of the United States of America 91:8 (1994), 3014–3018.
69. Predescu, S.A., Predescu, D.N., Malik, A.B., Molecular determinants of endothelial transcytosis and their role in endothelial permeability. American Journal of Physiology—Lung Cellular and Molecular Physiology 293:4 (2007), L823–L842, 10.1152/ajplung.00436.2006.
70. Predescu, S.A., Predescu, D.N., Palade, G.E., Endothelial transcytotic machinery involves supramolecular protein–lipid complexes. Molecular Biology of the Cell 12:4 (2001), 1019–1033.
71. Rejman, J., Oberle, V., Zuhorn, I.S., Hoekstra, D., Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochemical Journal 377:Pt. 1 (2004), 159–169, 10.1042/bj20031253.
72. Ren, J., Shen, S., Wang, D., Xi, Z., Guo, L., Pang, Z.,.. Jiang, X., The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials 33:11 (2012), 3324–3333 http://dx.doi.org/10.1016/j.biomaterials.2012.01.025.
73. Roberts, R., Sandra, A., Siek, G.C., Lucas, J.J., Fine, R.E., Studies of the mechanism of iron transport across the blood-brain barrier. Annals of Neurology 32:S1 (1992), S43–S50, 10.1002/ana.410320709.
74. Sawyer, S.T., Krantz, S.B., Transferrin receptor number, synthesis, and endocytosis during erythropoietin-induced maturation of Friend virus-infected erythroid cells. Journal of Biological Chemistry 261:20 (1986), 9187–9195.
75. Schnitzer, J.E., Oh, P., Pinney, E., Allard, J., Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. The Journal of Cell Biology 127:5 (1994), 1217–1232, 10.1083/jcb.127.5.1217.
76. Schoch, S., Deák, F., Königstorfer, A., Mozhayeva, M., Sara, Y., Südhof, T.C., Kavalali, E.T., SNARE function analyzed in synaptobrevin/VAMP knockout mice. Science 294:5544 (2001), 1117–1122, 10.1126/science.1064335.
77. Schröder, U., Sabel, B.A., Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain Research 710:1–2 (1996), 121–124 http://dx.doi.org/10.1016/0006-8993(95)01375-X.
78. Shibata, M., Yamada, S., Kumar, S.R., Calero, M., Bading, J., Frangione, B.,.. Zlokovic, B.V., Clearance of Alzheimer's amyloid-β(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. Journal of Clinical Investigation 106:12 (2000), 1489–1499.
79. Simionescu, M., Popov, D., Sima, A., Endothelial transcytosis in health and disease. Cell and Tissue Research 335 (2008), 27–40.
80. Sollner, T., Whiteheart, S.W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., Rothman, J.E., SNAP receptors implicated in vesicle targeting and fusion. Nature 362:6418 (1993), 318–324.
81. Stern, D., Du Yan, S., Fang Yan, S., Marie Schmidt, A., Receptor for advanced glycation endproducts: A multiligand receptor magnifying cell stress in diverse pathologic settings. Advanced Drug Delivery Reviews 54:12 (2002), 1615–1625 http://dx.doi.org/10.1016/S0169-409X(02)00160-6.
82. Stojanov, K., Georgieva, J.V., Brinkhuis, R.P., van Hest, J.C., Rutjes, F.P., Dierckx, R.A.J.O.,.. Zuhorn, I.S., In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice. Molecular Pharmaceutics 9:6 (2012), 1620–1627, 10.1021/mp200621v.
83. Südhof, T.C., Rothman, J.E., Membrane fusion: Grappling with SNARE and SM proteins. Science (New York, N.Y.) 323:5913 (2009), 474–477, 10.1126/science.1161748.
84. Sztul, E., Colombo, M., Stahl, P., Samanta, R., Control of protein traffic between distinct plasma membrane domains. Requirement for a novel 108,000 protein in the fusion of transcytotic vesicles with the apical plasma membrane. Journal of Biological Chemistry 268:3 (1993), 1876–1885.
85. Tian, X., Nyberg, S., Sharp, P.S., Madsen, J., Daneshpour, N., Armes, S.P.,.. Battaglia, G., LRP-1-mediated intracellular antibody delivery to the central nervous system. Scientific Reports, 5, 2015, 11990, 10.1038/srep11990 http://www.nature.com/articles/srep11990 supplementary-information.
86. Toonen, R.F., Kochubey, O., de Wit, H., Gulyas-Kovacs, A., Konijnenburg, B., Sørensen, J.B.,.. Verhage, M., Dissecting docking and tethering of secretory vesicles at the target membrane. The EMBO Journal 25:16 (2006), 3725–3737, 10.1038/sj.emboj.7601256.
87. Tuma, P.L., Hubbard, A.L., Transcytosis: Crossing cellular barriers. Physiological Reviews 83:3 (2003), 871–932, 10.1152/physrev.00001.2003.
88. Ulbrich, K., Hekmatara, T., Herbert, E., Kreuter, J., Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB). European Journal of Pharmaceutics and Biopharmaceutics 71:2 (2009), 251–256 http://dx.doi.org/10.1016/j.ejpb.2008.08.021.
89. Visser, C.C., Voorwinden, L.H., Crommelin, D.J.A., Danhof, M., de Boer, A.G., Characterization and modulation of the transferrin receptor on brain capillary endothelial cells. Pharmaceutical Research 21:5 (2004), 761–769, 10.1023/B:PHAM.0000026425.69874.8e.
90. Wiley, D.T., Webster, P., Gale, A., Davis, M.E., Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proceedings of the National Academy of Sciences of the United States of America 110:21 (2013), 8662–8667, 10.1073/pnas.1307152110.
91. Winkler, J., Ramirez, G.A., Kuhn, H.G., Peterson, D.A., Day-Lollini, P.A., Stewart, G.R.,.. Thal, L.J., Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor. Annals of Neurology 41:1 (1997), 82–93, 10.1002/ana.410410114.
92. Xu, T., Binz, T., Niemann, H., Neher, E., Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity. Nature Neuroscience 1:3 (1998), 192–200, 10.1038/642.
93. Yamada, K., Kinoshita, A., Kohmura, E., Sakaguchi, T., Taguchi, J., Kataoka, K., Hayakawa, T., Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction. Journal of Cerebral Blood Flow & Metabolism 11:3 (1991), 472–478, 10.1038/jcbfm.1991.90.
94. Yu, Y.J., Atwal, J.K., Zhang, Y., Tong, R.K., Wildsmith, K.R., Tan, C.,.. Watts, R.J., Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates. Science Translational Medicine, 6(261), 2014, 261ra154, 10.1126/scitranslmed.3009835.
95. Yu, Y.J., Zhang, Y., Kenrick, M., Hoyte, K., Luk, W., Lu, Y.,.. Dennis, M.S., Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Science Translational Medicine, 3(84), 2011, 84ra44, 10.1126/scitranslmed.3002230.
96. Zhang, S., Li, J., Lykotrafitis, G., Bao, G., Suresh, S., Size-dependent endocytosis of nanoparticles. Advanced Materials (Deerfield Beach, Fla.) 21 (2009), 419–424, 10.1002/adma.200801393.
97. Zlokovic, B.V., Skundric, D.S., Segal, M.B., Lipovac, M.N., Mackic, J.B., Davson, H., A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig. Experimental Neurology 107:3 (1990), 263–270 http://dx.doi.org/10.1016/0014-4886(90)90144-H.